US equities
|
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
MU
$878.84
▼-5.63%
NVDA
$214.13
▼-1.43%
TSLA
$354.72
▼-2.13%
AAPL
$343.46
▲+0.43%
META
$709.33
▼-3.72%
MSFT
$529.05
▼-1.93%
SPCX
$146.03
▼-1.74%
AMD
$528.75
▼-5.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Sequel Med Tech
twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
October 16, 2026
From
Sequel Med Tech
Via
GlobeNewswire
Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions
June 08, 2026
From
Sequel Med Tech
Via
GlobeNewswire
Sequel Brings twiist™ Nationwide, Redefining Automated Insulin Delivery Category with Industry-First Innovation
March 09, 2026
From
Sequel Med Tech
Via
GlobeNewswire
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
February 19, 2026
From
Sequel Med Tech
Via
GlobeNewswire
Tickers
SENS
Sequel Med Tech to Integrate twiist Automated Insulin Delivery (AID) System with Abbott’s Future Dual Glucose-Ketone Sensor
May 22, 2025
From
Sequel Med Tech
Via
GlobeNewswire
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
April 29, 2025
From
Sequel Med Tech
Via
GlobeNewswire
Sequel Announces First CGM Integration for its twiist AID System: Abbott's FreeStyle Libre 3 Plus Sensor
March 18, 2025
From
Sequel Med Tech
Via
GlobeNewswire
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024
From
Sequel Med Tech
Via
GlobeNewswire